Sleep Test Coverage Policy, ResMed/Respironics Talks Could Awaken Market

ResMed plans to work with Respironics to generate data that will raise the public and professional profile of sleep-disordered breathing (SDB) devices, which have an estimated $600 mil. U.S. market potential